Evaluation of the Effectiveness of Ginkgo Biloba regimen on cognitive function in patients undergoing electroconvulsive therapy: Double blind clinical trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200516047470N1

Enrollment

Registered

2020-08-21

Start date

2020-04-08

Completion date

Unknown

Last updated

2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychosis. Other stimulant related disorders

Interventions

Intervention 1: Intervention group: Ginkgo biloba administrated 48 hours before shock therapy. The case group given 6-12 bilateral or unilateral ECT sessions (3 times a week) and one Ginkgo biloba tab

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: All patients admitted to the psychiatric ward of ?Ahvaz Golestan Hospital aged 18 to 60 years whose illness has been confirmed by a psychiatrist

Exclusion criteria

Exclusion criteria: History of epilepsy History of coagulation disorders History of alcohol and drug abuse History of drug allergy Patients who have received electroconvulsive therapy in the last 6 months before study

Design outcomes

Primary

Measure	Time frame
Mini-Mental State Examination. Timepoint: Before, during and after the intervention. Method of measurement: Mini-Mental State Examination Scale.;Memory. Timepoint: Before, during and after the intervention. Method of measurement: Wechsler Memory Scale III.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactElham Zeynali

Ahvaz University of Medical Sciences

zeynali_e@ajums.ac.ir+98 61 3374 3038

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026